IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v43y2025i10d10.1007_s40273-025-01520-0.html
   My bibliography  Save this article

Challenges in Modelling the Cost Effectiveness of Pharmacotherapies for Obesity

Author

Listed:
  • Becky Pennington

    (University of Sheffield)

  • Ewen Cummins

    (McMDC Ltd)

  • Albany Chandler

    (National Institute for Health and Care Excellence)

  • James Fotheringham

    (University of Sheffield
    Sheffield Kidney Institute, Sheffield Teaching Hospitals NHS Trust)

Abstract

The cost effectiveness of pharmacotherapies for obesity (such as semaglutide, tirzepatide, liraglutide, and newer agents) is increasingly being appraised by health technology assessment (HTA) bodies. Modelling is required to extrapolate weight change observed over relatively short clinical trial durations to long-term weight loss and associated cardio-metabolic outcomes and costs. Extrapolation is a common issue in HTA, but there is a unique challenge for anti-obesity drugs because of the number of interacting uncertainties. This is a particular concern given the substantial eligible population sizes and associated high financial decision risk of providing lifetime treatment. We describe four key challenges in modelling pharmacotherapies for obesity: (1) modelling long-term body mass index (BMI) trajectories with and without obesity pharmacotherapy, (2) modelling time on treatment, (3) using risk equations to link changes in BMI to clinical outcomes, and (4) modelling clinical outcomes not (solely) related to BMI changes. We discuss each of these challenges and the impact they have had in global HTA appraisals for pharmacotherapies. We speculate how these challenges relating to short-term clinical trials could be overcome to more robustly predict long-term outcomes and the role that observational data may play. As clinical trial and real-world evidence for technologies for obesity evolves, analysts and decision-makers need to determine which evidence sources are most appropriate and how they should be combined.

Suggested Citation

  • Becky Pennington & Ewen Cummins & Albany Chandler & James Fotheringham, 2025. "Challenges in Modelling the Cost Effectiveness of Pharmacotherapies for Obesity," PharmacoEconomics, Springer, vol. 43(10), pages 1171-1178, October.
    • Handle: RePEc:spr:pharme:v:43:y:2025:i:10:d:10.1007_s40273-025-01520-0
    DOI: 10.1007/s40273-025-01520-0
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40273-025-01520-0
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40273-025-01520-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to

    for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:43:y:2025:i:10:d:10.1007_s40273-025-01520-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.